Increased in vitro glial fibrillary acidic protein expression, telomerase activity, and telomere length after productive human immunodeficiency virus-1 infection in murine astrocytes

Journal of Neuroscience Research

Volumn 92, Issue 2, 2014, Pages 267-274

  Ojeda, Diego ^a   López Costa, Juan José ^a   Sede, Mariano ^a   López, Ester María ^a   Berria, María Isabel ^a   Quarleri, Jorge ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Astrocytes; GFAP; HIV 1; Telomerase; Telomere length

Indexed keywords

ANTIGEN P24; GLIAL FIBRILLARY ACIDIC PROTEIN; TELOMERASE; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MOUSE; NEURAL STEM CELL; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TELOMERE HOMEOSTASIS; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

ASTROCYTES; GFAP; HIV-1; TELOMERASE; TELOMERE LENGTH;

AIDS DEMENTIA COMPLEX; ANIMALS; ASTROCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HIV-1; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE;

EID: 84890115573     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23294     Document Type: Article

References (61)

1. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284-291.
2. Aiken C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 71:5871-5877.
3. Antinori A, et al. 2007. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799.
4. Ashraf T, Ronaldson PT, Persidsky Y, Bendayan R. 2011. Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes. J Neurosci Res 89:1773-1782.
5. Ausubel MF, Kingston ER, Moore DD, Seidman GJ, Smith AJ, Struhl K, editors. 1995. Current protocols in molecular biology New York: John Wiley & Sons, Inc.
6. Bagheri S, et al. 2006. Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A 103:11306-11311.
7. Ballon G, Ometto L, Righetti E, Cattelan AM, Masiero S, Zanchetta M, Chieco-Bianchi L, DeRossi A. 2001. Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis 183:417-424.
8. Bartz SR, Rogel ME, Emerman M. 1996. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 70:2324-2331.
9. Bell JE, Anthony IC, Simmonds P. 2006. Impact of HIV on regional and cellular organisation of the brain. Curr HIV Res 4:249-257.
10. Berria MI, Lascano EF. 1985. Astrocyte differentiation induced by Junin virus in rat brain cell cultures. Acta Neuropathol 66:233-238.
11. Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ, Sell C, Torres C. 2012. Astrocyte senescence as a component of Alzheimer's disease. PLoS One 7:e45069.
12. Borda T, Gomez R, Berria MI, Sterin-Borda L. 2004. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera. Glia 45:144-154.
13. Borjabad A, Brooks AI, Volsky DJ. 2010. Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5:44-62.
14. Bryan TM, Reddel RR. 1997. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33:767-773.
15. Canki M, Thai JN, Chao W, Ghorpade A, Potash MJ, Volsky DJ. 2001. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 75:7925-7933.
16. Cawthon RM. 2002. Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47.
17. Cawthon RM. 2009. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21.
18. Chung HK, Cheong C, Song J, Lee HW. 2005. Extratelomeric functions of telomerase. Curr Mol Med 5:233-241.
19. Clifford DB. 2008. HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med 16:94-98.
20. + T lymphocytes. Mol Immunol 54:181-192.
21. Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ. 1987. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol 61:3774-3782.
22. Du F, Qian ZM, Zhu L, Wu XM, Qian C, Chan R, Ke Y. 2010. Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures. J Cell Biochem 109:30-37.
23. Eugenin EA, Clements JE, Zink MC, Berman JW. 2011. Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31:9456-9465.
24. Fan Y, Zou W, Green LA, Kim BO, He JJ. 2011. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity. J Neuroimmune Pharmacol 6:121-129.
25. Fehrer C, Voglauer R, Wieser M, Pfister G, Brunauer R, Cioca D, Grubeck-Loebenstein B, Lepperdinger G. 2006. Techniques in gerontology: cell lines as standards for telomere length and telomerase activity assessment. Exp Gerontol 41:648-651.
26. Flanary BE, Streit WJ. 2004. Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 45:75-88.
27. + T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1). J Med Virol 79:639-646.
28. Fu W, Killen M, Culmsee C, Dhar S, Pandita TK, Mattson MP. 2000. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J Mol Neurosci 14:3-15.
29. Gonzalez-Scarano F, Martin-Garcia J. 2005. The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81.
30. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, Vesselingh SL, Purcell DF. 2003. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 1:463-473.
31. Gras G, Kaul M. 2010. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 7:30.
32. Herbert BS, Hochreiter AE, Wright WE, Shay JW. 2006. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc 1:1583-1590.
33. Hochreiter AE, Xiao H, Goldblatt EM, Gryaznov SM, Miller KD, Badve S, Sledge GW, Herbert BS. 2006. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin Cancer Res 12:3184-3192.
34. Jacobs S, Doering LC. 2010. Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci 30:4508-4514.
35. Jaskelioff M, et al. 2011. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102-106.
36. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. 2005. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12(Suppl 1):878-892.
37. Labombarda F, Gonzalez SL, Deniselle MC, Vinson GP, Schumacher M, DeNicola AF, Guennoun R. 2003. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J Neurochem 87:902-913.
38. + signaling, mitochondria and sensitivity to oxidative stress in aging astrocytes. Neurobiol Aging 28:99-111.
39. Malan-Muller S, Hemmings SM, Spies G, Kidd M, Fennema-Notestine C, Seedat S. 2013. Shorter telomere length-a potential susceptibility factor for HIV-associated neurocognitive impairments in South African woman. PLoS One 8:e58351.
40. Massard C, Zermati Y, Pauleau AL, Larochette N, Metivier D, Sabatier L, Kroemer G, Soria JC. 2006. hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 25:4505-4514.
41. Middeldorp J, Hol EM. 2011. GFAP in health and disease. Prog Neurobiol 93:421-443.
42. Miura T, Katakura Y, Yamamoto K, Uehara N, Tsuchiya T, Kim EH, Shirahata S. 2001. Neural stem cells lose telomerase activity upon differentiating into astrocytes. Cytotechnology 36:137-144.
43. Nandakumar J, Cech TR. 2013. Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 14:69-82.
44. Nitkiewicz J, Chao W, Bentsman G, Li J, Kim SY, Choi SY, Grunig G, Gelbard H, Potash MJ, Volsky DJ. 2004. Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in culture. J Neurovirol 10:400-408.
45. Passos JF, Saretzki G, vonZglinicki T. 2007. DNA damage in telomeres and mitochondria during cellular senescence: is there a connection? Nucleic Acids Res 35:7505-7513.
46. Pertusa M, Garcia-Matas S, Rodriguez-Farre E, Sanfeliu C, Cristofol R. 2007. Astrocytes aged in vitro show a decreased neuroprotective capacity. J Neurochem 101:794-805.
47. Pollicita M, et al. 2009. Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line. BMC Neurosci 10:51.
48. Price TO, Ercal N, Nakaoke R, Banks WA. 2005. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 1045:57-63.
49. Qu Y, Duan Z, Zhao F, Wei D, Zhang J, Tang B, Li J, Yang C, Mu D. 2011. Telomerase reverse transcriptase upregulation attenuates astrocyte proliferation and promotes neuronal survival in the hypoxic-ischemic rat brain. Stroke 42:3542-3550.
50. Reynoso R, Minces L, Salomon H, Quarleri J. 2006. HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level. AIDS Res Hum Retroviruses 22:425-429.
51. Reynoso R, Laufer N, Bolcic F, Quarleri J. 2010. Telomerase activity in peripheral blood mononuclear cells from HIV and HIV-HCV coinfected patients. Virus Res 147:284-287.
52. Reynoso R, Wieser M, Ojeda D, Bonisch M, Kuhnel H, Bolcic F, Quendler H, Grillari J, Grillari-Voglauer R, Quarleri J. 2012. HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs. J Virol 86:10327-10337.
53. Riol H, Fages C, Tardy M. 1992. Transcriptional regulation of glial fibrillary acidic protein (GFAP)-mRNA expression during postnatal development of mouse brain. J Neurosci Res 32:79-85.
54. Shahabuddin M, Volsky B, Kim H, Sakai K, Volsky DJ. 1992. Regulated expression of human immunodeficiency virus type 1 in human glial cells: induction of dormant virus. Pathobiology 60:195-205.
55. Smith LL, Coller HA, Roberts JM. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-479.
56. Spudich S, González Scarano F. 2012. HIV-related central nervous system disease: current issues in pathogenesis, diagnosis and treatment. Cold Spring Harbor Perspect Med 2:a007120.
57. Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, Mosley RL, Volsky DJ, Ciborowski P, Gendelman HE. 2008. Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3:e2507.
58. Williams DW, Eugenin EA, Calderon TM, Berman JW. 2012. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91:401-415.
59. Zhou BY, Liu Y, Kim B, Xiao Y, He JJ. 2004. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci 27:296-305.
60. Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ. 2007. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am J Pathol 171:1923-1935.
61. Zou W, Wang Z, Liu Y, Fan Y, Zhou BY, Yang XF, He JJ. 2010. Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes. Glia 58:1640-1648.